The FDA Is Now Using Generative AI to Review Submissions. Here’s What That Means for Pharma Teams
On May 8, 2025, the U.S. Food and Drug Administration announced the completion of its first AI-assisted scientific review pilot. Alongside that announcement came a clear directive: generative AI capab...